CLYM vs INDP: stock comparison and AI forecast
Climb Bio, Inc. (CLYM) and Indaptus Therapeutics, Inc. (INDP) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
CLYM Climb Bio, Inc.
- Market Cap
- $509M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
INDP Indaptus Therapeutics, Inc.
- Market Cap
- $498M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- CLYM and INDP have similar market capitalizations ($509M and $498M).
- INDP carries 0.05 times debt per unit of equity, against 0.04 times for CLYM.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | CLYM | INDP |
|---|---|---|
| Market Cap | $509M | $498M |
| P/B Ratio | 2.23x | 43.75x |
| EPS | $-0.87 | $-3.55 |
| Book Value/Share | $3.97 | $0.07 |
Profitability & Margins
| Metric | CLYM | INDP |
|---|---|---|
| ROE | -26.0% | – |
| ROA | -25.1% | – |
| ROIC | -29.2% | – |
| Tax Rate | 0.0% | – |
Financial Health
| Metric | CLYM | INDP |
|---|---|---|
| Current Ratio | 26.58x | – |
| D/E Ratio | 0.04x | 0.05x |
| Financial Leverage | 1.04x | 1.05x |
| Working Capital | $202M | – |
Cash Flow
| Metric | CLYM | INDP |
|---|---|---|
| Operating Cash Flow | -$53M | -$15M |
Income Statement
| Metric | CLYM | INDP |
|---|---|---|
| Operating Income | -$67M | -$15M |
| Net Income | -$59M | – |
| R&D Expense | $44M | $5M |
Dividend & Shareholder Information
| Metric | CLYM | INDP |
|---|---|---|
| Shares Outstanding | 57M | 154M |
| EPS Growth | -495.4% | – |
CLYM vs INDP: stock comparison and AI forecast
Which is bigger, CLYM or INDP?
CLYM and INDP have similar market capitalizations ($509M and $498M).
Which one does Intratio's AI model rank higher, CLYM or INDP?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.